Societal Burden Associated With Type 1 Diabetes in Canada
- Conditions
- Type 1 Diabetes MellitusQuality of Life (QOL)Work ProductivityCaregiver Subjective Burden
- Registration Number
- NCT06786130
- Lead Sponsor
- PeriPharm
- Brief Summary
The purpose of this observational study is to estimate the burden of T1D on caregivers of patient with T1D in terms of work productivity, healthcare resource utilization and quality of life.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 100
- Parental caregiver of a child recently diagnosed (<= 2 years) with T1D before study inclusion;
- Age ≥18 ;
- Residence in the Canada;
- Willingess to complete a 20-minute survey
- Ability to read and understand French or English;
- Signature of informed consent form (ICF)
- Participation in a clinical trial.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To estimate work productivity impairment of caregivers of a T1D child. At recruitment Using the WOrk Productivity and Activity Impairment (WPAI) questionnaire
- Secondary Outcome Measures
Name Time Method To estimate healthcare resource utilization in caregivers of T1D child At recruitment Using the modified Resource Utilization Questionnaire for Type 1 Diabetes (mRUQ-T1DM) questionnaire.
To estimate health-related quality of life in caregivers of a T1D child At recruitment Using the EuroQOL-5 dimension-5 levels (EQ-5D-5L) questionnaire.
To estimate the caregiver burden in caregivers of a T1D child At recruitment Using the Zarit Burden Interview-22 (ZBI-22) questionnaire.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
PROxy Network, an initiative of PeriPharm Inc.
🇨🇦Montreal, Quebec, Canada
PROxy Network, an initiative of PeriPharm Inc.🇨🇦Montreal, Quebec, CanadaCatherine Beauchemin, PhDContact514-731-8207catherine.beauchemin@peripharm.com